SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-13-054334
Filing Date
2013-10-17
Accepted
2013-10-17 19:59:23
Documents
2
Period of Report
2013-10-14

Document Format Files

Seq Description Document Type Size
1 FORM 3 rrd393043.html 3  
1 FORM 3 rrd393043.xml 3 1434
2 POWER OF ATTORNEY rrd353602_400492.htm EX-24. 3312
  Complete submission text file 0001181431-13-054334.txt   6172
Mailing Address 4660 LA JOLLA VILLAGE DRIVE, SUITE 1070 SAN DIEGO CA 92122
Business Address 4660 LA JOLLA VILLAGE DRIVE, SUITE 1070 SAN DIEGO CA 92122 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Issuer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O LA JOLLA PHARMACEUTICAL COMPANY LA JOLLA VILLAGE DRIVE, SUITE 1070 SAN DIEGO CA 92122
Business Address
Douglass Laura L. (Reporting) CIK: 0001589362 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-24274 | Film No.: 131158020